JoVE Logo

S'identifier

5.22 : Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:

Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common cold-associated rhinorrhea and allergic rhinitis.

Gastrointestinal Tract: Hyoscine and scopolamine relax gastrointestinal smooth muscles, aiding in endoscopy and gastrointestinal radiology procedures. Pirenzepine is preferred for peptic ulcers due to its receptor specificity, while glycopyrrolate and dicyclomine are used to treat irritable bowel syndrome. They reduce functional and nervous diarrhea and control Parkinson's-associated salivation.
Neurological Conditions: Antimuscarinics such as benzhexol, trihexyphenidyl, and benztropine are used to manage Parkinson's disease and antipsychotic-induced extrapyramidal side effects. They suppress cholinergic neurotransmission in the basal ganglia, reducing tremors associated with Parkinson's disease.
Ophthalmic Applications: Homatropine, cyclopentolate, and tropicamide are topically administered for eye examinations and for treating ocular conditions.

Urinary Tract: Antimuscarinics like oxybutynin, tolterodine, trospium, darifenacin, solifenacin, and fesoterodine are used to treat overactive bladder and enuresis in children.

Motion Sickness: Transdermal scopolamine is effective in preventing motion sickness.

Cardiovascular Applications: Atropine treats sinus bradycardia and partial heart block following myocardial infarction.

Antidote for Poisoning: Antimuscarinics serve as antidotes for organophosphorus insecticide poisoning.

It is worth noting that non-selective antimuscarinic agents may cause undesirable side effects, leading to poor long-term patient compliance. Selective agents with receptor or organ specificity exhibit fewer adverse effects, resulting in better patient compliance.

Tags

Cholinergic AntagonistsAntimuscarinic DrugsTherapeutic ApplicationsRespiratory TractIpratropiumAsthmaChronic BronchitisCOPDGastrointestinal TractHyoscineScopolamineParkinson s DiseaseNeurological ConditionsOcular ConditionsUrinary TractOveractive BladderMotion SicknessAtropineOrganophosphorus Poisoning

Du chapitre 5:

article

Now Playing

5.22 : Cholinergic Antagonists: Therapeutic Uses

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

708 Vues

article

5.1 : Système nerveux autonome : aperçu

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

3.7K Vues

article

5.2 : Transmission neurochimique : sites d’action du médicament

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

2.1K Vues

article

5.3 : Classification des neurotransmetteurs

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

2.6K Vues

article

5.4 : Neurones cholinergiques : Neurotransmission

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

2.6K Vues

article

5.5 : Récepteurs cholinergiques : Muscariniques

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

1.9K Vues

article

5.6 : Récepteurs cholinergiques : nicotiniques

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

2.4K Vues

article

5.7 : Agonistes cholinergiques à action directe : chimie et relation structure-activité

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

855 Vues

article

5.8 : Agonistes cholinergiques à action directe : pharmacocinétique

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

1.0K Vues

article

5.9 : Agonistes cholinergiques à action directe : actions pharmacologiques

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

1.2K Vues

article

5.10 : Agonistes cholinergiques à action directe : utilisations thérapeutiques

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

682 Vues

article

5.11 : Cholinestérases : distribution et fonction

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

402 Vues

article

5.12 : Agonistes cholinergiques à action indirecte : chimie et relation structure-activité

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

516 Vues

article

5.13 : Agonistes cholinergiques à action indirecte : mécanisme d’action

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

1.6K Vues

article

5.14 : Agonistes cholinergiques à action indirecte : pharmacocinétique

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

908 Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.